What is the current Price Target for the Xenon Pharmaceuticals Inc. stock?

The average Xenon Pharmaceuticals Inc. target price is $57.81. This is 96.64% higher than the current stock price. The highest price target is 121.09%, the lowest is 42.86%. 16 Analysts have issued a price target Xenon Pharmaceuticals Inc. 2026 .

How high will the Xenon Pharmaceuticals Inc. stock rise?

No reliable answer can be given as to how high the Xenon Pharmaceuticals Inc. stock will rise. The performance of stocks, including the Xenon Pharmaceuticals Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Xenon Pharmaceuticals Inc. stock today?

The performance of Xenon Pharmaceuticals Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Xenon Pharmaceuticals Inc. stock fall?

The decline in Xenon Pharmaceuticals Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Xenon Pharmaceuticals Inc. Forecast, price target & analysts

$29.40

4.27% yesterday

Nasdaq, Apr 04, 10:00 pm CET

ISIN

CA98420N1050

Symbol

XENE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Xenon Pharmaceuticals Inc. Target price 2025 - Analyst rating & recommendation

Xenon Pharmaceuticals Inc. Classifications & Recommendation:

Buy

100%

Xenon Pharmaceuticals Inc. Price Target

Target Price	$57.81
Price	$29.40
Potential	96.64% register free of charge
Number of Estimates	16

	16 Analysts have issued a price target Xenon Pharmaceuticals Inc. 2026 . The average Xenon Pharmaceuticals Inc. target price is $57.81. This is 96.64% register free of charge higher than the current stock price. The highest price target is $65.00 121.09% register free of charge , the lowest is $42.00 42.86% register free of charge .
	A rating was issued by 17 analysts: 17 Analysts recommend Xenon Pharmaceuticals Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Xenon Pharmaceuticals Inc. stock has an average upside potential 2026 of 96.64% register free of charge . Most analysts recommend the Xenon Pharmaceuticals Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-3.01	-4.11
	10.26%	36.54%
P/E		negative
EV/Sales		735.76

9 Analysts have issued a Xenon Pharmaceuticals Inc. forecast for earnings per share. The average Xenon Pharmaceuticals Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-3.01	10.26%
2025	$-4.11 36.54% Unlock
2026	$-4.47 8.76% Unlock
2027	$-3.94 11.86% Unlock
2028	$-0.04 98.98% Unlock
2029	$2.66 6,750.00% Unlock

Current	-9.78	37.98%
2025	-7.15 26.89% Unlock
2026	-6.58 7.97% Unlock
2027	-7.47 13.53% Unlock
2028	-725.69 9,614.73% Unlock
2029	11.07 101.53% Unlock

Xenon Pharmaceuticals Inc....

Current Xenon Pharmaceuticals Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 24 2025
Deutsche Bank	Locked ➜ Locked	Locked	Feb 11 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 12 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 13 2024
Needham	Locked ➜ Locked	Locked	Nov 13 2024
Raymond James	Locked ➜ Locked	Locked	Oct 10 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 01 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 24 2025
Locked Deutsche Bank: Locked ➜ Locked	Feb 11 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 12 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 13 2024
Locked Needham: Locked ➜ Locked	Nov 13 2024
Locked Raymond James: Locked ➜ Locked	Oct 10 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 01 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 95.20%

BioNTech SE - ADR 57.25%

Amazon.com 55.96%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now